Shopping Cart
- Remove All
Your shopping cart is currently empty
AGN 192836 is a potent and selective α2 adrenergic agonist with EC50s of 8.7 nM, 41 nM, and 6.6 nM for the α2A, α2B, and α2C receptors, respectively.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,080 | 8-10 weeks | |
| 50 mg | $1,410 | 8-10 weeks | |
| 100 mg | $2,220 | 8-10 weeks |
| Description | AGN 192836 is a potent and selective α2 adrenergic agonist with EC50s of 8.7 nM, 41 nM, and 6.6 nM for the α2A, α2B, and α2C receptors, respectively. |
| Targets&IC50 | α2A:(EC50)8.7 nM , α2B: 41 nM , α2C: 6.6 nM |
| In vitro | AGN 192836 is 1200-fold selective for the α2A-receptor relative to the α1-receptor, 50-fold selective for the α2A-receptor relative to the α2B-receptor, and 10-fold selective for the α2Areceptor relative to the α2C-receptor. |
| In vivo | AGN 192836 demonstrates equivalent efficacy to brimonidine in lowering intraocular pressure when topically applied to rabbits and surpasses brimonidine's effectiveness in reducing blood pressure through intravenous administration in monkeys. |
| Molecular Weight | 231.25 |
| Formula | C12H13N3O2 |
| Cas No. | 171102-29-7 |
| Relative Density. | 1.342 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.